TWST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Twist Bioscience Corp (TWST) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong growth potential driven by its innovative technology and AI-driven demand in wet lab/data markets. Despite some insider selling and hedge fund reductions, the stock's technical indicators, analyst ratings, and options sentiment suggest a favorable long-term outlook.
The stock is in a strong bullish trend with the MACD histogram positively expanding above zero, RSI at 80.747 indicating overbought conditions, and moving averages showing bullish alignment (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at R1: 85.495 and R2: 90.694, with the current price already above R1, suggesting strong momentum.
Analysts have consistently raised price targets, with recent targets ranging from $85 to $90, citing the company's innovative silicon-based DNA synthesis technology and scalability.
The stock has appreciated significantly over the past year (58.97%), reflecting investor confidence.
The company's positioning to meet growing AI-driven demands in wet lab/data markets is a significant growth driver.
Hedge funds have significantly increased selling activity (634.68% increase over the last quarter).
Insider selling by Jan Johannessen, though attributed to option exercises, may raise concerns for some investors.
The RSI indicates overbought conditions, suggesting potential for short-term pullbacks.
No detailed financial data is available for the latest quarter. However, analysts have noted broad-based momentum and raised revenue guidance for 2026, indicating strong growth expectations.
Analysts are overwhelmingly positive on TWST, with multiple Buy ratings and price targets raised recently. TD Cowen, Canaccord, and Piper Sandler have highlighted the company's innovative technology and long-term growth potential. The average price target is around $87-$90, aligning with the current price.
